system
caus
cholestasi
constitut
divers
group
diseas
across
organ
system
pathophysiolog
cholestasi
system
diseas
consequ
direct
involv
diseas
process
within
liver
extrahepat
biliari
system
secondari
immunemedi
chang
bile
flow
tabl
evalu
patient
cholestasi
system
caus
requir
understand
patient
risk
factor
clinic
set
eg
hospit
immunosuppress
patient
clinic
featur
pattern
laboratori
abnorm
nearli
signific
extrahepat
bacteri
infect
caus
cholestasi
osler
describ
jaundic
occur
curiou
irregular
patient
pneumonia
first
edit
principl
practic
medicin
bacteri
infect
necessarili
involv
liver
bile
duct
may
lead
jaundic
sepsi
frequent
link
cholestasi
particularli
intens
care
unit
set
tabl
gramposit
gramneg
organ
potenti
culpabl
escherichia
coli
common
isol
retrospect
analysi
jaundic
develop
onethird
neonat
infant
sepsi
incid
adult
patient
estim
rang
cholestasi
infect
sepsi
second
common
caus
jaundic
hospit
patient
malign
biliari
obstruct
adult
conjug
hyperbilirubinemia
typic
less
mgdl
predomin
bilirubin
level
higher
neonat
consequ
underdevelop
efflux
capac
serum
alkalin
phosphatas
level
time
upper
limit
normal
typic
wherea
aminotransferas
level
either
normal
modestli
increas
apart
jaundic
symptom
pruritu
clinic
sign
hepatomegali
uncommon
treatment
support
fluid
resuscit
antibiot
one
prospect
analysi
find
associ
presenc
jaundic
increas
mortal
pathophysiolog
cholestasi
sepsi
topic
sever
excel
review
kupffer
cell
lesser
extent
hepatocyt
sinusoid
endotheli
cell
react
bacteri
endotoxin
lipopolysaccharid
elabor
proinflammatori
cytokin
tumor
necrosi
factor
interleukin
endotoxemia
rat
shown
caus
downregul
bile
uptak
na
taurochol
cotransport
polypeptid
organ
aniontransport
polypeptid
export
bile
salt
export
pump
multidrug
resist
protein
transport
cholestasi
posttranscript
mechan
favor
studi
involv
human
liver
tissu
nitric
oxid
free
radic
hepat
microvasculatur
contribut
endotheli
damag
format
fibrin
microthrombi
histolog
hepatocellular
canalicular
bilirubinostasi
predomin
often
nonspecif
portalbas
inflamm
kupffer
cell
hyperplasia
distinct
cholestat
pictur
term
progress
scleros
cholang
emerg
set
sever
septic
shock
entiti
may
evolv
result
biliari
ischemia
system
hypotens
also
describ
extens
trauma
burn
pathophysiolog
poorli
understood
like
involv
similar
diminut
express
bile
transport
result
cytokin
induct
well
stasi
toxic
bile
salt
within
duct
cirrhosi
result
certain
system
bacteri
organ
capabl
infect
liver
directli
predilect
cholestasi
increas
serum
alkalin
phosphatas
level
jaundic
frequent
accompani
pyogen
liver
abscess
recent
case
seri
indic
liver
abscess
cryptogen
therefor
consid
system
actinomycosi
caus
actinomyc
israelii
filament
gramposit
rod
present
liver
involv
rare
instanc
wherea
hepat
abscess
common
present
actinomycosi
affect
patient
may
also
follow
indol
cours
fever
abdomin
pain
anorexia
associ
nearli
univers
increas
serum
alkalin
phosphatas
level
biopsi
infect
tissu
show
characterist
sulfur
granul
treatment
penicillin
tetracyclin
usual
cur
sever
shigellosi
caus
cholestat
hepat
portal
periport
polymorphonuclear
inflammatori
infiltr
wherea
yersiniosi
produc
granulomat
hepat
patient
diabet
mellitu
predispos
iron
load
certain
zoonot
infect
particularli
brucellosi
also
may
lead
cholestasi
develop
jaundic
may
correl
sever
ill
necrot
hepat
granuloma
occur
hepat
lobul
portal
tract
associ
focal
mononuclear
infiltr
weil
syndrom
develop
patient
leptospirosi
spirochet
infect
acquir
warm
climat
water
contamin
urin
wild
domest
anim
jaundic
week
may
denot
first
phase
ill
follow
fever
subsequ
hepat
renal
injuri
delemo
friedman
conjug
hyperbilirubinemia
reflect
intrahepat
cholestasi
along
hypertrophi
kupffer
cell
appar
liver
biopsi
specimen
anoth
spirochet
infect
associ
cholestasi
syphili
caus
lymphocyt
portal
triaditi
pericholangiolar
inflamm
markedli
increas
serum
alkalin
phosphatas
level
fig
syphilit
hepat
person
infect
human
immunodefici
viru
hiv
well
describ
case
seri
patient
averag
serum
bilirubin
level
diagnosi
mgdl
tickborn
ill
q
fever
rocki
mountain
spot
fever
ehrlichiosi
infect
liver
caus
cholestasi
rare
instanc
compon
hemolysi
undoubtedli
contribut
jaundic
system
mycos
consid
opportunist
pathogen
infrequ
hepat
involv
high
index
suspicion
appropri
set
crucial
expedit
treatment
appropri
clinic
context
fungal
pathogen
dissemin
liver
lead
vari
degre
cholestasi
immunocompromis
patient
hepat
candidiasi
present
suppur
granuloma
neutrophil
inflamm
edema
surround
bile
duct
high
fever
increas
serum
alkalin
phosphatas
level
typic
featur
infect
yeast
cryptococcu
neoforman
present
sever
hepat
manifest
includ
jaundic
caus
cholang
bucuvala
colleagu
describ
girl
right
upper
quadrant
pain
jaundic
cryptococci
cultur
bile
duct
tissu
stain
india
ink
highlight
capsul
detect
serum
cryptococc
antigen
diagnost
test
choic
hepatitislik
pictur
may
develop
case
dissemin
coccidioidomycosi
endem
southwest
unit
state
affect
immunocompet
host
pulmonari
infiltr
granulomat
hepat
conjunct
markedli
increas
serum
alkalin
phosphatas
level
classic
present
histoplasmosi
spread
lung
liver
well
gener
immunocompromis
host
cholestasi
result
histoplasmosi
typic
occur
secondarili
develop
hemophagocyt
syndrom
see
later
discuss
hepatobiliari
tuberculosi
rare
although
well
document
experi
close
patient
tuberculosi
identifi
case
hepatobiliari
tuberculosi
multiorgan
involv
jaundic
classic
caus
extrahepat
biliari
obstruct
bulki
lymphadenopathi
around
porta
hepati
postinflammatori
biliari
strictur
characterist
granulomat
hepat
mark
fever
anorexia
weight
loss
night
sweat
infiltr
cholestasi
present
patient
miliari
tuberculosi
dissemin
mycobacterium
avium
complex
mac
infect
also
present
dramat
cholestasi
minim
increas
serum
aminotransferas
level
mac
infect
becom
infrequ
patient
hiv
infect
sinc
avail
effect
antiretrovir
therapi
viral
diseas
occur
latent
infect
reactiv
immunocompromis
host
de
novo
infect
otherwis
healthi
person
epsteinbarr
viru
ebv
cytomegaloviru
cmv
dna
virus
herpesviru
famili
involv
liver
either
scenario
jaundic
acut
mononucleosi
occur
case
contrast
ebv
reactiv
subsequ
develop
posttranspl
lymphoprolif
disord
ptld
often
character
jaundic
liver
transplant
recipi
see
later
discuss
similar
mononucleosislik
ill
occur
healthi
patient
acut
cmv
infect
character
patholog
focal
hepatocyt
bile
duct
damag
cmv
infect
specif
cholestat
featur
certain
immunocompromis
set
neonat
obstruct
biliari
diseas
neonat
giant
cell
hepat
cholestasi
occur
jaundic
found
infant
infect
perinat
cmv
case
seri
saudi
arabia
cmv
infect
patient
aid
caus
hiv
cholangiopathi
infecti
form
scleros
cholang
rare
seen
cmv
infect
usual
occur
month
solid
organ
transplant
typic
character
acut
hepat
patholog
featur
liver
cmv
inclus
foci
microabscess
agarw
colleagu
sever
viral
infect
influenza
sever
acut
respiratori
syndrom
believ
associ
immunemedi
liver
damag
result
cytokin
activ
neither
infect
gener
lead
cholestasi
contrast
measl
rubeola
may
result
pattern
hepat
dysfunct
commonli
asymptomat
increas
serum
aminotransferas
level
rare
prolong
jaundic
cholestasi
develop
usual
symptom
measl
resolv
typic
sarcoidosi
present
noncas
granuloma
lung
lymph
node
liver
occasion
extrapulmonari
site
diseas
retrospect
seri
liver
biochem
test
abnorm
found
patient
sarcoidosi
believ
hepat
sarcoidosi
preval
rate
highest
among
african
american
scandinavian
person
age
year
liver
involv
sarcoidosi
usual
clinic
silent
patient
experi
symptom
nausea
vomit
abdomin
pain
sign
hepatomegali
jaundic
portal
hypertens
abnorm
liver
biochem
test
level
identifi
patient
underw
liver
biopsi
case
seri
serum
alkalin
phosphatas
level
disproportion
high
addit
untreat
patient
sarcoidosi
increas
serum
angiotensinconvert
enzym
level
pathognomon
lesion
noncas
granuloma
result
helper
cell
type
respons
asyetunidentifi
antigen
patholog
hepat
sarcoidosi
indistinguish
primari
biliari
cirrhosi
primari
scleros
cholang
although
granuloma
seen
within
hepat
lobul
princip
find
portal
tract
includ
varieti
bile
duct
lesion
acut
chronic
cholang
periduct
fibrosi
bile
duct
loss
fig
presinusoid
portal
hypertens
develop
scar
portal
venul
gener
treatment
recommend
patient
asymptomat
hepat
diseas
advis
symptom
portal
hypertens
sever
cholestasi
appar
although
patient
may
improv
symptomat
glucocorticoid
ursodeoxychol
acid
structur
chang
bile
duct
progress
biliari
cirrhosi
result
case
need
liver
transplant
system
amyloidosi
may
primari
al
secondari
aa
precipit
immunoglobulin
light
chain
character
al
amyloid
develop
context
plasma
cell
dyscrasia
waldenstrom
macroglobulinemia
multipl
myeloma
although
heart
kidney
peripher
nerv
commonli
affect
organ
autopsi
seri
primari
amyloidosi
report
liver
involv
case
mayo
clinic
studi
report
natur
histori
patient
liver
biopsyproven
al
amyloid
period
unintent
weight
loss
hepatomegali
examin
frequent
present
symptom
serum
alkalin
phosphatas
level
strikingli
increas
median
valu
ul
normal
level
ul
normal
patient
median
surviv
month
patient
alkalin
phosphatas
level
greater
ul
month
total
bilirubin
level
greater
mgdl
patient
amyloid
deposit
detect
biopsi
specimen
extrahepat
tissu
well
treatment
choic
primari
amyloidosi
chemotherapi
possibl
hematopoiet
stemcel
transplant
secondari
aa
amyloidosi
develop
set
system
inflammatori
disord
rheumatoid
arthriti
chronic
infect
osteomyel
tuberculosi
patholog
protein
involv
serum
amyloid
acutephas
reactant
produc
perpetu
liver
respons
inflammatori
cytokin
amyloidogen
protein
deposit
extracellular
matric
variou
organ
al
diseas
prevent
process
occur
identifi
treat
underli
inflammatori
condit
paramount
manag
affect
patient
aa
amyloidosi
less
common
al
amyloidosi
histopatholog
find
similar
protein
deposit
space
diss
portal
tract
vessel
wall
caus
architectur
distort
cholestasi
fig
congo
red
stain
continu
mainstay
identifi
tissuebas
amyloid
hemophagocyt
syndrom
hemophagocyt
lymphohistiocytosi
hlh
rare
condit
involv
prolifer
macrophag
respons
phagocytosi
blood
cell
hematopoiet
organ
hematolog
malign
infect
histoplasmosi
tuberculosi
cmv
infect
hiv
infect
autoimmun
diseas
rheumatoid
arthriti
system
lupu
erythematosu
still
diseas
provok
sustain
immun
activ
delemo
friedman
histiocyt
natur
killer
nk
cell
cytotox
lymphocyt
germlin
mutat
perforin
found
famili
case
hlh
perforin
cytolyt
protein
express
nk
cell
cytotox
cell
critic
induc
apoptosi
infect
cell
clinic
featur
hlh
includ
fever
hepatosplenomegali
cytopenia
least
cell
line
hypertriglyceridemia
hypofibrinogenemia
high
serum
ferritin
level
case
seri
franc
patient
hepat
hlh
previou
diagnosi
lymphoma
leukemia
nineteen
patient
admit
hospit
hepat
manifest
diseas
includ
jaundic
liver
biopsi
perform
patient
case
show
hemophagocytosi
kupffer
cell
hyperplasia
sinusoid
dilat
origin
cohort
death
caus
multiorgan
failur
sepsi
fifteen
patient
could
treat
achiev
complet
remiss
high
serum
bilirubin
alkalin
phosphatas
level
associ
poorer
prognosi
hlh
glucocorticoidrespons
diseas
current
therapi
combin
dexamethason
etoposid
follow
allogen
hematopoiet
stemcel
transplant
case
genet
hlh
context
hematolog
malign
cholestasi
caus
sickl
cell
diseas
result
process
extrahepat
intrahepat
extrahepat
cholestasi
caus
choledocholithiasi
pigment
gallston
develop
roughli
onehalf
patient
sickl
cell
diseas
seri
patient
sickl
cell
diseas
underw
cholecystectomi
bile
duct
stone
found
patient
hospit
sickl
cell
crisi
hepat
complic
caus
sickl
found
hepat
crisi
mimic
acut
cholecyst
cholang
right
upper
quadrant
pain
jaundic
hepatomegali
fever
much
hyperbilirubinemia
attribut
conjug
bilirubin
total
bilirubin
level
rel
increas
aminotransferas
level
sickl
cell
intrahepat
cholestasi
scic
term
use
literatur
describ
acut
hepat
failur
sickl
cell
diseas
bilirubinostasi
identifi
patholog
liver
consequ
sinusoid
distens
erythrocyt
sickl
erythrophagocytosi
hemosiderosi
also
characterist
histolog
find
scic
associ
profound
hyperbilirubinemia
treat
success
occasion
case
exchang
transfus
liver
transplant
import
oncolog
caus
cholestasi
includ
hodgkin
lymphoma
hl
nonhodgkin
lymphoma
nhl
liver
involv
less
frequent
hl
nhl
typic
occur
diseas
diaphragm
stage
iii
dissemin
extranod
diseas
stage
iv
five
percent
patient
hl
liver
involv
time
diagnosi
reedsternberg
cell
pathognomon
forti
percent
patient
increas
serum
alkalin
phosphatas
level
intrahepat
tumor
infiltr
seen
jaundic
patient
hl
autopsi
sever
investig
report
intrahepat
cholestasi
caus
vanish
bile
duct
syndrom
hl
absenc
tumor
infiltr
ballonoff
colleagu
review
case
describ
literatur
found
associ
improv
cholestasi
complet
delemo
friedman
page
clin
liver
di
author
manuscript
avail
pmc
march
respons
chemotherapi
radiat
therapi
acut
liver
failur
potenti
complic
hl
either
directli
caus
hepat
infiltr
secondarili
caus
paraneoplast
process
liver
involv
nhl
patholog
characterist
similar
hl
includ
nodular
tumor
infiltr
portal
tract
epithelioid
granuloma
howev
primari
hepat
lymphoma
phl
rare
account
less
case
nhl
phl
defin
absenc
lymphoma
involv
spleen
lymph
node
bone
marrow
time
diagnosi
b
symptom
fever
weight
loss
occur
onethird
patient
common
present
abdomin
pain
caus
hepatomegali
serum
alkalin
phosphatas
bilirubin
level
increas
case
solitari
lesion
frequent
find
radiograph
encount
case
estim
prognosi
phl
difficult
condit
rare
nodular
oppos
diffus
infiltr
diseas
may
favor
outcom
chemotherapi
surviv
rate
respect
although
case
report
hepat
cassoci
phl
increas
risk
nhl
diffus
larg
bcell
lymphoma
margin
zone
lymphoma
lymphoplasmocyt
lymphoma
patient
chronic
hepat
c
specif
associ
increas
risk
phl
solid
organ
hematopoiet
stemcel
transplant
recipi
risk
ptld
type
nhl
driven
case
ebv
infect
see
earlier
discuss
ptld
complic
approxim
liver
transplant
liver
spleen
involv
ptld
unusu
occur
patient
experi
univers
pittsburgh
present
liver
ptld
caus
intrahepat
cholestasi
extrahepat
cholestasi
bulki
lymphadenopathi
around
porta
hepati
hepatosplen
tcell
lymphoma
hstcl
rare
aggress
lymphoma
infiltr
hepat
sinusoid
male
patient
younger
year
inflammatori
bowel
diseas
ibd
least
histori
exposur
combin
thiopurin
biolog
therapi
may
increas
risk
develop
hstcl
stauffer
syndrom
origin
term
nephrogen
hepat
dysfunct
refer
rare
paraneoplast
complic
renal
cell
carcinoma
overexpress
tumor
believ
play
role
pathophysiolog
cholestasi
typic
resolv
within
month
surgic
resect
primari
tumor
hepat
dysfunct
resect
may
portend
tumor
recurr
present
cholestasi
sometim
jaundic
usual
right
upper
quadrant
pain
caus
hepatomegali
liver
biopsi
specimen
show
nonspecif
chang
includ
steatosi
portal
lymphocyt
inflamm
kupffer
cell
hyperplasia
renal
cell
carcinoma
also
metastas
pancrea
caus
obstruct
jaundic
biliari
obstruct
caus
primari
metastat
cancer
head
pancrea
ampulla
bile
duct
common
caus
obstruct
jaundic
gastrointestin
tract
liver
often
affect
acut
graftversushost
diseas
gvhd
acut
hepat
gvhd
occur
first
day
allogen
stemcel
transplant
gvhd
aris
expans
popul
donor
cell
transplant
recipi
risk
factor
develop
gvhd
includ
hla
mismatch
gender
mismatch
high
number
cell
transfus
donor
liver
involv
typic
follow
skin
gastrointestin
involv
profound
cholestasi
develop
prognosi
poor
serum
bilirubin
level
greater
mgdl
establish
diagnosi
sever
gvhd
pathophysiolog
complex
like
involv
constel
immunemedi
featur
includ
cytokin
activ
endotheli
damag
condit
regimen
mani
antigenpres
cell
target
organ
histolog
lymphocyt
seen
infiltr
small
bile
duct
epitheli
cell
undergo
apoptosi
ursodeoxychol
acid
effect
prevent
hepat
gvhd
administ
prophylaxi
first
day
hematopoiet
stemcel
transplant
immunosuppress
foundat
therapi
gvhd
chronic
liver
gvhd
occur
destruct
bile
duct
damag
also
characterist
progress
fibrosi
unusu
except
case
concomit
chronic
liver
diseas
hepat
c
thyroid
diseas
may
affect
hepat
dysfunct
distinct
circumst
primari
biliari
cirrhosi
hypothyroid
may
occur
togeth
share
autoimmun
pathogenesi
jaundic
patient
myxedema
coma
typic
caus
acut
hepat
congest
heart
failur
sever
report
adult
pediatr
literatur
describ
cholestat
hepat
occur
patient
grave
diseas
mild
increas
serum
alkalin
phosphatas
level
occur
patient
hyperthyroid
although
increas
also
aris
bone
simultan
heart
failur
may
complic
recognit
hepat
dysfunct
caus
thyrotox
crisi
eventu
acut
liver
failur
liver
affect
patient
diabet
mellitu
commonli
nonalcohol
fatti
liver
diseas
harrison
colleagu
coin
term
diabet
hepatosclerosi
dh
review
liver
biopsi
specimen
patient
longstand
diabet
mellitu
salient
featur
includ
absenc
steatosi
dens
perisinusoid
fibrosi
origin
descript
includ
patient
diabet
mellitu
normal
bodi
mass
index
calcul
weight
kilogram
divid
squar
height
meter
evid
microvascular
complic
increas
serum
alkalin
phosphatas
level
larger
followup
autopsi
seri
investig
find
associ
cholestasi
nevertheless
dh
believ
repres
hepat
form
microvascular
diseas
patient
diabet
mellitu
hepat
congest
associ
modest
hyperbilirubinemia
patient
respect
retrospect
cohort
studi
patient
royal
cornwal
hospit
england
refer
period
jaundic
hotlin
found
primari
cardiac
caus
cholestasi
hyperbilirubinemia
heart
failur
typic
unconjug
serum
bilirubin
level
less
mgdl
conjug
associ
higher
bilirubin
level
jaundic
may
becom
wors
repeat
episod
heart
failur
often
associ
cardiac
index
less
lminm
patholog
lowflow
state
heart
failur
result
reduc
oxygen
tension
caus
zone
hepat
necrosi
ischem
biliari
chang
cholestasi
bile
thrombi
format
bilirubinostasi
also
postul
occur
result
extrins
compress
sinusoid
hepat
venul
dilat
ischem
hepat
shock
liver
result
myocardi
infarct
massiv
pulmonari
embolu
arrhythmia
cardiac
tamponad
distinct
entiti
character
increas
serum
aminotransferas
level
least
time
upper
limit
normal
rapid
return
normal
similarli
high
serum
lactat
dehydrogenas
level
characterist
seeto
colleagu
compar
patient
ischem
hepat
patient
hypovolem
shock
secondari
trauma
found
averag
total
bilirubin
level
mgdl
ischem
hepat
cohort
compar
mgdl
traumat
shock
group
classic
peak
serum
bilirubin
occur
aminotransferas
level
declin
cholestasi
may
occur
cours
sever
autoimmun
diseas
autoimmun
scleros
cholang
diseas
discuss
elsewher
issu
dr
saul
karpen
sever
system
autoimmun
condit
may
associ
primari
autoimmun
liver
diseas
particular
syndrom
system
sclerosi
may
coexist
primari
biliari
cirrhosi
serum
alkalin
phosphatas
level
may
increas
system
lupu
erythematosu
rheumatoid
arthriti
cholestasi
uncommon
concomit
pharmacolog
therapi
joint
bone
involv
diseas
may
led
misinterpret
increas
alkalin
phosphatas
level
cholestasi
older
case
seri
purpura
hsp
clearli
associ
cholestasi
hsp
common
system
vascul
childhood
character
palpabl
purpura
least
follow
abdomin
pain
iga
deposit
biopsi
specimen
arthriti
renal
involv
diseas
typic
evolv
set
viral
infect
parvoviru
upper
respiratori
infect
bacteri
infect
group
streptococcu
salmonella
shigella
campylobact
spp
predispos
malign
nonsmal
cell
lung
cancer
lymphoma
often
note
adult
leukocytoclast
vascul
involv
gallbladd
caus
acut
acalcul
cholecyst
peribiliari
vessel
may
affect
therebi
result
biliari
ischemia
stenosi
bile
duct
obstruct
jaundic
ibd
may
associ
primari
autoimmun
cholestat
liver
diseas
primari
scleros
cholang
diseas
addit
granulomat
hepat
delemo
friedman
character
increas
serum
alkalin
phosphatas
level
well
describ
patient
crohn
diseas
bile
salt
malabsorpt
ileal
resect
crohn
diseas
increas
risk
cholelithiasi
caus
biliari
obstruct
bile
duct
stone
celiac
diseas
associ
increas
aminotransferas
level
mani
case
occasion
advanc
liver
diseas
increas
alkalin
phosphatas
level
less
common
may
caus
bone
involv
secondari
hyperparathyroid
consequ
parenter
nutrit
develop
cholestat
liver
diseas
review
detail
elsewher
issu
cholestasi
neonat
especi
problemat
progress
lifethreaten
liver
dysfunct
incid
parenter
nutritionassoci
liver
complic
decreas
neonat
time
durat
parenter
nutrit
infant
correl
risk
develop
progress
cholestat
jaundic
day
parenter
nutrit
canalicular
cholestasi
present
infant
week
bile
duct
prolifer
found
infant
pathogenesi
parenter
nutritionassoci
cholestasi
multifactori
neonat
liver
immatur
unabl
excret
bile
salt
normal
rate
therebi
lead
bile
acid
toxic
particularli
secondari
bile
acid
lithochol
bacteri
transloc
across
underdevelop
unus
segment
intestin
caus
system
endotoxemia
contribut
cholestasi
context
alter
postsurg
anatomi
eg
bypass
short
bowel
absent
ileocec
valv
enter
intak
stimul
bile
flow
result
cholecystokinin
cck
releas
absenc
cck
gallbladd
dysmotil
occur
result
biliari
sludg
gallston
even
acalcul
cholecyst
hepat
steatosi
common
manifest
adult
patient
parenter
nutrit
cholestasi
biliari
sludg
gallston
also
encount
earli
resumpt
oral
intak
critic
prevent
develop
parenter
nutritionassoci
cholestasi
cycl
parenter
nutrit
infus
allow
normal
insulin
counterregulatori
hormon
level
ursodeoxychol
acid
effect
prevent
cholestasi
patient
short
bowel
syndrom
longterm
parenter
nutrit
evalu
patient
system
cholestasi
requir
care
attent
clinic
circumst
fig
gener
exclus
druginduc
cholestasi
parenter
nutritioninduc
cholestasi
biliari
obstruct
use
first
step
inpati
outpati
cholestasi
intens
care
unit
rais
suspicion
sepsi
syndrom
particularli
pediatr
patient
popul
sever
hypovolem
shock
caus
ischem
cholangiopathi
character
pronounc
cholestasi
adult
inpati
mild
hyperbilirubinemia
detail
cardiopulmonari
physic
examin
transthorac
echocardiographi
use
exclud
heart
failur
mark
increas
serum
aminotransferas
level
accompani
jaundic
suggest
ischem
hepat
cholestasi
immunocompromis
patient
prompt
detail
clinic
histori
evid
infecti
exposur
comprehens
workup
infecti
organ
follow
transplant
recipi
evalu
ptld
evalu
includ
serum
lactat
dehydrogenas
level
ebv
viral
load
often
crosssect
imag
positron
emiss
tomographi
evalu
obstruct
lymphadenopathi
ultrasonographi
warrant
hepat
sarcoidosi
typic
histolog
diagnosi
chest
imag
serum
angiotensinconvert
enzym
level
usual
help
strike
cholestasi
set
weight
loss
hepatosplenomegali
highli
suggest
system
malign
hepat
involv
especi
lymphoma
well
amyloidosi
either
case
pursu
tissu
diagnosi
necessari
although
liver
tissu
specif
essenti
cholestasi
set
system
autoimmun
diseas
prompt
evalu
primari
autoimmun
cholestat
liver
diseas
primari
biliari
cirrhosi
primari
scleros
cholang
extrahepat
sourc
alkalin
phosphatas
exclud
evid
cholestasi
increas
alkalin
phosphatas
level
liver
biopsi
usual
definit
procedur
choic
diagnosi
remain
uncertain
comprehens
noninvas
evalu
evalu
patient
system
cholestasi
requir
meticul
approach
treatment
direct
toward
underli
caus
profound
system
inflammatori
respons
sepsi
disrupt
elimin
bile
salt
level
hepatocyt
provok
cholestasi
detail
clinic
histori
includ
travel
exposur
underli
immunosuppress
crucial
evalu
patient
cholestasi
system
autoimmun
diseas
associ
cholestasi
trigger
evalu
primari
autoimmun
cholestat
liver
diseas
hallmark
hepat
amyloidosi
lymphoma
promin
increas
serum
alkalin
phosphatas
level
